A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy
Clinical trial NCT02798952 · COMPLETED
Trial details
- NCT number
- NCT02798952
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-23
- Primary completion
- 2017-07-05
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.